| Name | Title | Contact Details |
|---|---|---|
Mark Tapsak |
Vice President of Sensor Technology | Profile |
In a complex healthcare world, Medline strives to help our customers achieve both clinical and financial success. We do that through a personalized approach to listen and better understand our customers` needs in an environment that tirelessly demands lower costs and better outcomes. We are both a manufacturer and distributor with 1,200 direct sales reps who are dedicated points of contact for customers across the continuum of care. Because of our capabilities and engagement with other clinical and industry thought leaders, we deliver the most robust product portfolio and patient-care solutions to help healthcare providers perform at their very best. Our responsiveness and commitment to advancing the health of healthcare is evident in our actions every day. This is who we are. This is why customers choose us as their trusted business partner.
Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk PCI and cardiogenic shock.
Intellijoint Surgical develops and commercializes surgical navigation solutions for total joint replacements. We are committed to improving patients` lives by providing every surgeon with effective, easy-to-use technology.
EPTAM Plastics is a Northfield, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world`s most prevalent eye diseases. The company`s surgical glaucoma product portfolio features the OMNI Surgical System, a dually indicated MIGS device that facilitates the performance of both ab interno trabeculotomy and transluminal viscoelastic delivery. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemm`s canal and collector channels) with a single device and single corneal incision. The company`s non-surgical dry eye product portfolio consists of the TearCare for ophthalmologists and optometrists. TearCare is a software-controlled, wearable, therapeutic eyelid technology designed to melt and clear obstructions of the meibomian glands within the eyelids. Leveraging the full functionality of the blinking eye, proprietary SmartLid™ technology is designed to conform to all eyelid anatomies and achieve therapeutic meibum melting temperatures at the tarsal conjunctiva thereby clearing meibomian gland obstructions while sparing the cornea. Improved meibum production results in a higher quality lipid layer and higher quality tears.